Clinical trial · Observational
A Case Report of NMDAR Encephalopathy
NCT06915103CI-TRIAL-00088267completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This case illustrates the clinical, radiologic, and histopathologic features of Anti-NMDAR encephalitis and underscores the importance of MRI in detecting ovarian teratomas when pelvic ultrasound is inconclusive.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anti-NMDA Receptor Encephalitis | — | UNRESOLVED | — |
| Mature Teratoma | Mature Teratoma | ONTOLOGY_EXACT | 0.90 |
| Paraneoplastic Syndromes | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Magnetic Resonance Imaging (MRI) | Diagnostic Test | — | UNRESOLVED |
| Salpingo-oophorectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Anti-NMDA Encephalitis
- timeFrame
- 1 week
- description
- Diagnosis of Anti-NMDA Encephalitis based on pelvic MRI
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 34 Years
- Maximum age
- 34 Years
Show eligibility criteria text
Inclusion Criteria: * Suspected Anti-NMDA Encephalitis Exclusion Criteria: * Inability to consent
References
Publications (0)
Data not yet available
No reference posted for this study.